Limited influence of dutasteride on individual prostate-specific antigen variability in men with clinical benign prostatic hyperplasia

Int J Urol. 2018 Jun;25(6):633-634. doi: 10.1111/iju.13557. Epub 2018 Apr 25.

Authors

Hideki Takeshita¹, Satoru Kawakami^{1

2}, Makoto Kagawa¹, Akihiro Yano¹, Yohei Okada¹, Makoto Morozumi¹

Affiliations

¹ Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
² Department of Urology, Harada Hospital, Iruma, Saitama, Japan.

PMID: 29693288
DOI: 10.1111/iju.13557

No abstract available

MeSH terms

5-alpha Reductase Inhibitors / pharmacology
5-alpha Reductase Inhibitors / therapeutic use*
Aged
Biological Variation, Population / drug effects*
Dutasteride / pharmacology
Dutasteride / therapeutic use*
Humans
Male
Prostate-Specific Antigen / blood*
Prostate-Specific Antigen / drug effects
Prostatic Hyperplasia / blood
Prostatic Hyperplasia / drug therapy*
Treatment Outcome

Substances

5-alpha Reductase Inhibitors
Prostate-Specific Antigen
Dutasteride